180 related articles for article (PubMed ID: 4611759)
1. Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin) in the treatment of diabetes insipidus in children.
Némethová V; Lichardus B
Endokrinologie; 1974 Mar; 63(1):137-41. PubMed ID: 4611759
[No Abstract] [Full Text] [Related]
2. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
Bernasconi S; Vanelli M; Giovannelli G
Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
[No Abstract] [Full Text] [Related]
3. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
[No Abstract] [Full Text] [Related]
4. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
Lebacq E; David L
Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
[No Abstract] [Full Text] [Related]
5. [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus].
Borner W; Froesch ER
Schweiz Med Wochenschr; 1974 Apr; 104(16):579-82. PubMed ID: 4827026
[No Abstract] [Full Text] [Related]
6. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
Limal JM; Mugner E; Czernichow P
Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
[TBL] [Abstract][Full Text] [Related]
7. [Studies of a new synthetic vasopressin derivative (DDAVP) in man].
Radó J; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Orv Hetil; 1976 Mar; 117(13):775-8. PubMed ID: 768869
[No Abstract] [Full Text] [Related]
8. [Letter: A synthetic analog of vasopressin (DDAVP). Value in the treatment of pitressin-sensitive diabetes insipidus].
Toursel F; Fontaine G
Nouv Presse Med; 1975 Jan; 4(3):190. PubMed ID: 1093122
[No Abstract] [Full Text] [Related]
9. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of diabetes insipidus with I-deamino-8-D-arginine-vasopressin].
Czakó L; László F
Orv Hetil; 1975 May; 116(20):1153-7. PubMed ID: 1134788
[No Abstract] [Full Text] [Related]
11. [Treatment with DDAVP in central diabetes insipidus. Review of our experience].
Bernasconi S; Vanelli M; Volta C; Solli R; Cavagni G; Giovannelli G
Minerva Pediatr; 1978 Jul; 30(13):1111-4. PubMed ID: 672852
[No Abstract] [Full Text] [Related]
12. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
[No Abstract] [Full Text] [Related]
13. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
Kauli R; Laron Z
Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
[No Abstract] [Full Text] [Related]
14. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Laczi F; Mezei G; Julesz J; Lázló FA
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus].
László C; János J; Ferenc L
Orv Hetil; 1977 Jul; 118(28):1648-50. PubMed ID: 876650
[No Abstract] [Full Text] [Related]
17. Treatment of central diabetes insipidus in adults and children with desmopressin.
Ziai F; Walter R; Rosenthal IM
Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
[TBL] [Abstract][Full Text] [Related]
18. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
Radó JP; Marosi J; Borbély L; Takó J
Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
[TBL] [Abstract][Full Text] [Related]
19. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
Radó JP; Marosi J; Fischer J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
[TBL] [Abstract][Full Text] [Related]
20. [A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa (author's transl)].
Schück O; Cort JH; Stríbrná J; Skopková J; Jost K
Cas Lek Cesk; 1975 Feb; 114(6):172-5. PubMed ID: 1092463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
